// App-Quantinova.ai

: Predictive Value of Thrombocytopenia in Antiphospholipid Syndrome

Researchers

Presenter

  • T. Moulinet

Principal Investigators

  • V. Dufrost

  • I. Clerc-Urmes

  • J. Risse

  • V. Eschwege

  • J. Devignes

  • K. Devreese

  • D. Wahl

  • S. Zuily

Medical Centers

  • Nancy University Hospital, Department of Internal Medicine and Clinical Immunology, Regional Competence Center for Rare and Systemic Autoimmune Disease, Vandœuvre‐lès‐Nancy, France

  • Lorraine University, Vandœuvre‐lès‐Nancy, France

  • Nancy University Hospital, Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, Vandœuvre‐lès‐Nancy, France

  • Nancy University Hospital, Platform of Clinical Research Support PARC (MDS unity), Vandœuvre‐lès‐Nancy, France

  • INSERM, UMR_S 1116, Vandœuvre‐lès‐Nancy, France

  • Nancy University Hospital, Haematology Laboratory and Haemostasis Unit, Vandœuvre‐lès‐Nancy, France

  • Ghent University Hospital, Coagulation Laboratory, Department of Clinical Chemistry, Microbiology, and Immunology, Ghent, Belgium

Locations

  • France

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Antiphospholipid syndrome

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A